Flagship Private Wealth, LLC Agios Pharmaceuticals, Inc. Transaction History

Flagship Private Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$41.92 - $58.18 $2,096 - $2,909	-50 Closed	0 $0
Q2 2021 Jul 09, 2021	SELL	$52.06 - $61.27 $145,247 - $170,943	-2,790 Reduced 98.24%	50 $2.84 Million
Q2 2021 Jul 09, 2021	BUY	$52.06 - $61.27 $145,247 - $170,943	2,790 Added 5580.0%	2,840 $156,000
Q4 2020 Feb 02, 2021	BUY	$33.21 - $46.54 $1,660 - $2,327	50 New	50 $2,000

233

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.78B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Flagship Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Private Wealth, LLC with notifications on news.